You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
According to the New York Times, Paul Marks, the former president and chief executive of Memorial Sloan Kettering Cancer Center, has died at 93.
As GenomeWeb reports, the Food and Drug Administration has issued an Emergency Use Authorization for a CRISPR-based test for SARS-CoV-2.
According to Mongabay, researchers are using genetics to trace the origins of shark fins found for sale.
In Science this week: mass spectrometric analysis of the SARS-CoV-2 spike protein, and more.
The Economist discusses the effect of the COVID-19 pandemic on how scientific research is communicated.
Researchers are wondering how the COVID-19 pandemic may affect results from clinical trials that continued and how to account for that influence, ScienceInsider reports.
NPR reports the US was behind on its payments to the World Health Organization when President Trump announced he'd be cutting off funding.
In Nature this week: method to cluster cells based on single-cell RNA sequencing reads, synthetic genomics platform reconstructs SARS-CoV-2, and more.
President Donald Trump said Tuesday the US coronavirus task force would be winding down, but then reversed himself Wednesday, saying it would continue its work indefinitely, CNBC reports.
The Washington Post reports former BARDA Director Rick Bright alleges in a whistleblower complaint he was removed from his post for trying to "prioritize science and safety over political expediency."
BBC News reports that a retrospective analysis of patient samples finds SARS-CoV-2 may have been introduced to France weeks earlier than thought.
In Genome Research this week: target-mismatched sgRNA in microbial genome editing, strategy to examine gene expression throughout the cell cycle, and more.
With new guidance, the US Food and Drug Administration tightens its oversight of SARS-CoV-2 antibody tests.
In a preprint, University of Bonn researchers report a SARS-CoV-2 infection rate of 15.5 percent in Gangelt, Germany.
The New York Times reports Pfizer and BioNTech have also started a trial of their mRNA-based vaccine for SARS-CoV-2 in the US.
In PNAS this week: biomarker of activity of protein encoded by HTRA1 in age-related macular degeneration, evolutionary history of lions, and more.
Early trials give conflicting results on remdesivir to treat COVID-19, though a large trial suggests it shortens disease length, Nature News reports.
The Guardian reports that the UK government has released the names of dozens of members of the Scientific Advisory Group for Emergencies.
According to New Scientist, the transatlantic slave trade may have introduced diseases like yaws and hepatitis B to the Americas.
In PLOS this week: gene alteration linked to glaucoma, genome sequencing traces origin of lager yeast, and more.
Genetic diversity in one gene appears to help the bacterium that causes syphilis evade the immune system.
The US Centers for Disease Control and Prevention has launched a SARS-CoV-2 genome sequencing consortium, the New York Times reports.
ScienceInsider writes that the National Institute of Health's termination of a grant studying how coronaviruses jump from bats to humans has raised concerns.
In Science this week: a microRNA regulates extracellular vesicle secretion from prostate cancer cells, and more.
A firm is examining sewage for SARS-CoV-2 as a means of monitoring the pandemic, the Los Angeles Times reports.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.